Plasma potentiates the priming effects of endotoxin on platelet activating factor-induced pulmonary hypertension in the rabbit lung

Anesthesia and Analgesia

Volumn 83, Issue 2, 1996, Pages 242-246

  Goldsmith, Jason A ^a   Kavanagh, Brian P ^a   Pearl, Ronald G ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD14 ANTIGEN; ESCHERICHIA COLI ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; THROMBOCYTE ACTIVATING FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTOXEMIA; GRAM NEGATIVE SEPSIS; INFLAMMATION; ISOLATED LUNG; LUNG ARTERY PRESSURE; LUNG INJURY; LUNG PERFUSION; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RABBIT;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIGENS, CD14; BLOOD PRESSURE; BLOOD PROTEINS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; ENDOTOXINS; ESCHERICHIA COLI; HYPERTENSION, PULMONARY; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; PLASMA; PLATELET ACTIVATING FACTOR; PULMONARY ARTERY; RABBITS; RESPIRATORY DISTRESS SYNDROME, ADULT; SERUM ALBUMIN;

EID: 0030016949     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199608000-00008     Document Type: Article

References (27)

1. Ghosh S, Latimer RD, Gray BM, et al. Endotoxin-induced organ injury. Crit Care Med 1993;21:S19-24.
2. Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 1986;133:913-27.
3. Meyrick BO, Ryan US, Brigham KL. Direct effects of E. coli endotoxin on structure and permeability of pulmonary endothelial monolayers and the endothelial layer of intimal explants. Am J Pathol 1986;1221:140-51.
4. Schumann RR, Leong SR, Flaggs GW, et al. Structure and function of lipopolysaccharide binding protein. Science 1990;249: 1429-31.
5. Wright SD, Ramos RA, Tobias PS, et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-3.
6. Wright SD, Ramos RA, Hermanowski-Vosatka A, et al. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J Exp Med 1991;173:1281-6.
7. Martin TR, Mathison JC, Tobias PS, et al. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. J Clin Invest 1992;90:2209-19.
8. Frey EA, Miller DS, Jahr TG, et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992;176: 1665-71.
9. Pugin J, Schurer-Maly CC, Leturcq D, et al. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993;90:2744-8.
10. Arditi M, Zhou J, Dorio R, et al. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect Immun 1993;61:3149-56.
11. Tobias PS, Mathison JC, Ulevitch RJ. A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J Biol Chem 1988;263:13479-81.
12. Martin TR, Rubenfeld G, Steinberg KP, et al. Endotoxin, endotoxin-binding protein, and soluble CD14 are present in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Chest 1994;105:55S-6S.
13. Mouchawar AM, Kavanagh BP, Pearl RG. Serum but not plasma produces injury in the perfused rabbit lung. Anesth Analg 1994; 79:40-5.
14. Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med 1991;174: 1517-26.
15. Clark BD, Collins KL, Gandy MS, et al. Genomic sequence for human prointerleukin 1 beta: possible evolution from a reverse transcribed prointerleukin 1 alpha gene. Nucleic Acids Res 1986; 14:7897-914.
16. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990;10:2327-34.
17. Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989;143:1366-71.
18. Neish AS, Williams AJ, Palmer HJ, et al. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 1992;176:1583-93.
19. Montgomery KF, Osborn L, Hession C, et al. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc Natl Acad Sci USA 1991;88:6523-7.
20. Read MA, Cordle SR, Veach RA, et al. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci USA 1993;90:9887-91.
21. Ishii Y, Wang Y, Haziot A, et al. Lipopolysaccharide binding protein and CD14 interaction induces tumor necrosis factor-alpha generation and neutrophil sequestration in lungs after intratracheal endotoxin. Circ Res 1993;73:15-23.
22. Goldblum SE, Brann TW, Ding X, et al. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. J Clin Invest 1994;93:692-702.
23. Doerfler ME, Weiss J, Clark JD, et al. Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85-kD cytosolic phospholipase A2. J Clin Invest 1994;93:1583-91.
24. Glaser KB, Asmis R, Dennis EA. Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Platelet-activating factor receptor activation and regulation of phospholipase A2. J Biol Chem 1990; 265:8658-64.
25. Salzer WL, McCall CE. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest 1990;85:1135-43.
26. 2+ mobilization and eicosanoid release in human Mono Mac 6 cells. J Immunol 1992;148:2186-93.
27. Walmrath D, Ghofrani HA, Rosseau S, et al. Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxin. J Exp Med 1994;180:1437-43.